Mayo Stephen 4
4 · Allogene Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Mayo Stephen
Director
Transactions
- Award
Stock Option (Right to buy)
2024-06-05+191,082→ 191,082 totalExercise: $2.44Exp: 2034-06-05→ Common Stock (191,082 underlying)
Footnotes (1)
- [F1]Vesting in 12 equal monthly installments